FDA.reportPublic FDA data

Hempvana Maximum Strength Pain Relief Cream - Night

Manufacturer
Telebrands Corp | Neutraderm, Inc.
Effective date
2021-05-25
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 22:44:25

Label at a glance#

ProductHempvana Maximum Strength Pain Relief Cream - Night
Active ingredientLIDOCAINE
Label structure8 sections

Indications and uses

Temporary relief of pain

Dosage and administration

For Use By Adults Only Apply generously to affected area Massage into painful area until thoroughly absorbed into skin. Repeat as necessary, but no more than 4 times daily.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Purpose

OTC - PURPOSE SECTION

Lidocaine 4%.......................Topical Analgesic

Uses

INDICATIONS & USAGE SECTION

Temporary relief of pain

Warnings

WARNINGS SECTION

For external use only

OTHER SAFETY INFORMATION

Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.

OTC - WHEN USING SECTION

When using this product

  • Use only as directed. Read and follow all directions and warnings on this label.
  • Do not bandage tightly or apply local heat (such as heating pads) to the area of use.
  • Avoid contact with eyes or mucous membranes.
  • Do not apply to wounds or damaged, broken or irritated skin.
  • Do not use at the same time as other topical analgesics.

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • Condition worsens
  • Symptoms persist for more than 7 days or clear up and occur again within a few days
  • Redness is present or irritation develops

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • For Use By Adults Only
  • Apply generously to affected area
  • Massage into painful area until thoroughly absorbed into skin.
  • Repeat as necessary, but no more than 4 times daily.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water/Aqua/Eau, Propylene Glycol, Ethylhexyl Palmitate, Dimethicone, Stearic Acid, Cannabis Sativa (Hemp) Seed Oil, Cetearyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Lavandula Angustifolia (Lavender) Oil, Melatonin, Piper Methysticum Root Extract, Anthemis Nobilis Flower Extract, Lavandula Angustifolia (Lavender) Flower Extract, Theobroma Cacao (Cocoa) Seed Butter, Potassium Cetyl Phosphate, Glycerin, Tocopheryl Acetate, Phenoxyethanol, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Caprylyl Glycol, Isohexadecane, Ethylhexylglycerin, Hexylene Glycol, Allantoin, Polysorbate 80, Disodium EDTA, Sodium Hydroxide, Red 4 (CI 14700), Blue 1 (CI 42090)

Questions?

OTC - QUESTIONS SECTION

Questions? Call (855) 877-4503 (M-F, 9am-5pm EST)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Hempvana

Maximum Strength

Pain Relief

Cream

Night with Calming Lavender

+ Hemp Seed Oil

Lidocaine 4%

Net Wt. 4 OZ (119 g)

11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 34 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73287-01573287-015-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 32 matching rows.

Name, UNII, Kind table
NameUNIIKind
PHENOXYETHANOLHIE492ZZ3TIACT
SODIUM ACRYLATE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER (4000000 MW)1DXE3F3OZXIACT
ISOHEXADECANE918X1OUF1EIACT
ETHYLHEXYLGLYCERIN147D247K3PIACT
ALLANTOIN344S277G0ZIACT
SODIUM HYDROXIDE55X04QC32IIACT
FD&C RED NO. 4X3W0AM1JLXIACT
FD&C BLUE NO. 1H3R47K3TBDIACT
CETOSTEARYL ALCOHOL2DMT128M1SIACT
MELATONINJL5DK93RCLIACT
CANNABIS SATIVA SEED OIL69VJ1LPN1SIACT
GLYCERYL MONOSTEARATE230OU9XXE4IACT
PEG-100 STEARATEYD01N1999RIACT
LAVENDER OILZBP1YXW0H8IACT
PIPER METHYSTICUM ROOTBOW48C81XPIACT
LAVANDULA ANGUSTIFOLIA FLOWER19AH1RAF4MIACT
POTASSIUM CETYL PHOSPHATE03KCY6P7UTIACT
WATER059QF0KO0RIACT
ETHYLHEXYL PALMITATE2865993309IACT
COCOA BUTTER512OYT1CRRIACT
EDETATE DISODIUM ANHYDROUS8NLQ36F6MMIACT
DIMETHICONE92RU3N3Y1OIACT
STEARIC ACID4ELV7Z65APIACT
CHAMAEMELUM NOBILE FLOWERO2T154T6OGIACT
GLYCERINPDC6A3C0OXIACT
.ALPHA.-TOCOPHEROL ACETATE9E8X80D2L0IACT
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)59TL3WG5COIACT
CAPRYLYL GLYCOL00YIU5438UIACT
HEXYLENE GLYCOLKEH0A3F75JIACT
POLYSORBATE 806OZP39ZG8HIACT
LIDOCAINE98PI200987ACTIB
PROPYLENE GLYCOL6DC9Q167V3IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c32f6d47-304c-7d6b-e053-2a95a90a1eecc22db841-7a0e-1d96-e053-2a95a90a67c52021-05-25WarningsExact identifier
spl id: c32f6d47-304c-7d6b-e053-2a95a90a1eec
spl set id: c22db841-7a0e-1d96-e053-2a95a90a67c5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.